Lantheus Selects GenesisCare to Administer First Commercial

Lantheus Selects GenesisCare to Administer First Commercial Dose of PYLARIFY®, the First and Only FDA-Approved PSMA PET Imaging Agent for Men with Prostate Cancer

© 2025 Vimarsana